We are looking for highly motivated postdoctoral fellows interested in investigating immune spatial heterogeneity in human cancers. These projects are based on high-dimensional tissue imaging of the tumor and associated microenvironment with single-cell protein expression analysis and subsequent integration of genomic DNA/RNA profiling. The intention is to better define the function and development of the tumor/immune ecosystem to ultimately improve patient immunotherapeutic selection and prognostication, to better understand and overcome therapeutic resistance and to improve our understanding of biologic states in space and time.
In this role you will:
Collaborate with quantitative experimentalists and computational scientists to conduct and publish research in a rapidly expanding investigational field with significant room for growth and ground-level development
Use new experimental tools and design novel methods and assays to address problems in human tumor immunology
Design and actualize high-dimensional spatial profiling studies within the immunopathology lab
Work with high dimensional imaging data from a variety of cutting-edge platforms such as MIBI, Codex, Vectra/Polaris and Nanostring GeoMx
Design strategies to analyze high dimensional imaging data
Integrate imaging data with genomic DNA/RNA profiling
Correlate findings with ongoing and recent clinical trials outcomes
Author journal papers and attend conferences
The ideal candidate should have:
PhD or MS degree in immunology
Publication record in biologic or quantitative sciences
Experience with R for data analysis and statistics
Coding skills (esp. Python) would be helpful
Recent graduates, MS, and PhD candidates who will defend soon are welcome
Interested applicants should apply including CV, a letter outlining your interest and names/contact infomraiton of three references.
Internal Number: 2020-41021
About Memorial Sloan-Kettering Cancer Center
As one of the world's premier cancer centers, Memorial Sloan-Kettering Cancer Center is committed to exceptional patient care, leading-edge research, and superb educational programs. The close collaboration between our physicians and scientists is one of our unique strengths, enabling us to provide patients with the best care available today as we work to discover more effective strategies to prevent, control, and ultimately cure cancer in the future. Our education programs train future physicians and scientists, and the knowledge and experience they gain at Memorial Sloan-Kettering has an impact on cancer treatment and the biomedical research agenda around the world.